Serotonin 1A agonist and cardiopulmonary improvements with whole-body exercise in acute, high-level spinal cord injury: a retrospective analysis
- 24 October 2020
- journal article
- research article
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 121 (2) , 453-463
Abstract
Purpose High-level spinal cord injury (SCI) can result in spinal and supraspinal respiratory control deficits leading to insufficient ventilatory responses to exercise and training-related adaptations. We hypothesized a serotonin agonist, known to improve respiratory function in animal models, would improve adaptations to whole-body functional electrical stimulation (FES) exercise training in patients with acute high-level SCI. Methods We identified 10 patients (< 2 years of injury with SCI from C4 to T3) in our program who had performed 6 months of FES-row training while on Buspirone (29 ± 17 mg/day) between 2012 and 2018. We also identified well-matched individuals who trained for six months but not on Buspirone (n = 11). A peak incremental FES-rowing exercise test and resting pulmonary function test had been performed before and after training. Results Those on Buspirone demonstrated greater increases in peak oxygen consumption (VO2peak: + 0.24 ± 0.23 vs. + 0.10 ± 0.13 L/min, p = 0.08) and peak ventilation (VEpeak: + 6.5 ± 8.1 vs. − 0.7 ± 6.9 L/min, p < 0.05) compared to control. In addition, changes in VO2peak and VEpeak were correlated across all patients (r = 0.63, p < 0.01), but most strongly in those on Buspirone (r = 0.85, p < 0.01). Furthermore, changes in respiratory function correlated with increased peak tidal volume in the Buspirone group (r > 0.66, p < 0.05). Conclusion These results suggest Buspirone improves cardiorespiratory adaptations to FES-exercise training in individuals with acute, high-level SCI. The strong association between increases in ventilatory and aerobic capacities suggests improved respiratory function is a mechanism; however, controlled studies are needed to determine if this preliminary finding is reproducible.Keywords
Funding Information
- National Institutes of Health (R01-HL-117037)
- National Institute on Disability, Independent Living, and Rehabilitation Research (90SI5021-01)
- Ellen R. and Melvin J. Gordon Center for the Cure and Treatment of Paralysis
- Fondation de la Recherche Médicale
This publication has 38 references indexed in Scilit:
- The Relationship of Walking Intensity to Total and Cause-Specific Mortality. Results from the National Walkers’ Health StudyPLOS ONE, 2013
- Functional and Physiological Effects of Treadmill Training Induced by Buspirone, Carbidopa, and L-DOPA in Clenbuterol-Treated Paraplegic MiceNeurorehabilitation and Neural Repair, 2011
- Aerobic Capacity With Hybrid FES Rowing in Spinal Cord Injury: Comparison With Arms‐Only Exercise and Preliminary Findings With Regular TrainingPM&R, 2011
- Buspirone in Rett syndrome respiratory dysfunctionBrain and Development, 2005
- Treatment of apneustic respiratory disturbance with a serotonin-receptor agonistThe Journal of Pediatrics, 1997
- Respiratory Muscles and Ventilatory Failure: 1993 PerspectiveThe American Journal of the Medical Sciences, 1993
- Buspirone Effect on Breathlessness and Exercise Performance in Patients with Chronic Obstructive Pulmonary DiseaseRespiration, 1993
- The NaKCl cotransport in essential hypertension: cellular functions and genetic environment interactionsInternational Journal of Cardiology, 1989
- Mechanism of Active Expiration in Tetraplegic SubjectsNew England Journal of Medicine, 1986
- Respiratory responses of the anesthetized rabbit to vagotomy and thoracic dorsal rhizotomyRespiration Physiology, 1973